Pain
Latest News
OTC cannabidiol products tied to improved pain, sleep, anxiety
“There are some data to suggest that there is an expectancy effect when we talk about the therapeutic benefit of cannabinoid products,” said Dr....
FDA/CDC
Orally dissolving buprenorphine tied to severe tooth decay, FDA warns
Since buprenorphine was approved, the FDA has identified 305 cases of dental problems associated with orally dissolving buprenorphine.
Latest News
One doctor’s psychedelic journey to confront his cancer
After psilocybin treatment, a person with cancer is often better able to talk about death and loss than their loved ones.
From the Journals
Study finds sharp drop in opioid scripts among most specialties
A study by the RAND Corp found U.S. clinicians are prescribing fewer opioids, with variation among patients. But the lead author said the report...
FDA/CDC
Califf plans work on opioids, accelerated approvals on return to FDA
In emphasizing the need for continued efforts to address risks of painkillers, Biden’s FDA nominee cites his relatives’ experience in getting 30-...
From the Journals
Ginger for migraine: A new review
Ginger has “long been recommended as an effective home remedy for the acute treatment of migraine, relieving both headache and the associated...
From the Journals
Short-acting opioids needed for withdrawal in U.S. hospitals, say experts
The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to...
FDA/CDC
U.S. overdose deaths hit an all-time high
Fentanyl and methamphetamine are contributing to rising numbers of fatalities, federal officials say.
Conference Coverage
Warn patients about illicit drugs doctored with fentanyl
Most patients with drug use disorders are testing positive for fentanyl at his center, said Dr. Edwin A. Salsitz, of Mount Sinai Beth Israel.
Conference Coverage
Cannabis use: Messages remain mixed across diagnoses
Medscape Live and this news organization are owned by the same parent company. Dr. Martinez and Dr. Sarris reported no financial conflicts of...
From the Journals
Good news, bad news for buprenorphine in opioid use disorder
The findings “underscore the need to pursue actions that expand access to buprenorphine-based OUD treatment,” said Dr. Beth Han and associates.